Literature DB >> 1377975

Molecular cloning of feline interferon cDNA by direct expression.

N Nakamura1, T Sudo, S Matsuda, A Yanai.   

Abstract

A cDNA sequence coding for feline interferon has been cloned for the first time by screening a cDNA library constructed using Okayama-Berg vector and mRNA derived from the feline cells (LSA-I) induced by TPA (12-o-tetradecanoylphorbor 13-acetate) for the ability of transient expression to produce feline interferon in COS1 monkey cells. The amino acid sequence, deduced from the nucleotide sequence by comparing it with the sequences of other mammalian IFNs, consists of 171 amino acids with 6 cysteins and an N-glycosylation site at the amino acid position 79, and has about 60% homology to human IFN alpha 1. The interferon was partially purified through Blue Sepharose, and its molecular weight was estimated to be 2.4 x 10(4). The antiviral activity was acid stable, and glycosylation was suggested.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377975     DOI: 10.1271/bbb.56.211

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  8 in total

1.  Novel recombinant feline interferon carrying N-glycans with reduced allergy risk produced by a transgenic silkworm system.

Authors:  Sachi Minagawa; Yuzuru Nakaso; Masahiro Tomita; Takenori Igarashi; Yoshio Miura; Hideyo Yasuda; Satoshi Sekiguchi
Journal:  BMC Vet Res       Date:  2018-08-31       Impact factor: 2.741

2.  Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats.

Authors:  Philippe R Hennet; Guy A L Camy; David M McGahie; Maxime V Albouy
Journal:  J Feline Med Surg       Date:  2011-08       Impact factor: 2.015

3.  The innate antiviral immune system of the cat: molecular tools for the measurement of its state of activation.

Authors:  Céline Robert-Tissot; Vera L Rüegger; Valentino Cattori; Marina L Meli; Barbara Riond; Maria Alice Gomes-Keller; Andrea Vögtlin; Burghardt Wittig; Christiane Juhls; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

Review 4.  Interferon-omega: Current status in clinical applications.

Authors:  Shi-Fang Li; Fu-Rong Zhao; Jun-Jun Shao; Yin-Li Xie; Hui-Yun Chang; Yong-Guang Zhang
Journal:  Int Immunopharmacol       Date:  2017-10-12       Impact factor: 4.932

5.  Use of recombinant interferon omega in feline retrovirosis: from theory to practice.

Authors:  Ana Doménech; Guadalupe Miró; Victorio M Collado; Natalia Ballesteros; Leticia Sanjosé; Elena Escolar; Sonsoles Martin; Esperanza Gomez-Lucia
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

6.  Induction of a systemic antiviral state in vivo in the domestic cat with a class A CpG oligonucleotide.

Authors:  Céline Robert-Tissot; Marina L Meli; Barbara Riond; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2012-08-04       Impact factor: 2.046

7.  Gene cloning, sequencing, expression and biological activity of giant panda (Ailuropoda melanoleuca) interferon-alpha.

Authors:  Xue-Mei Tan; Yang Tang; Yun-Fei Yang; Hong-Mei Song; Yi-Zheng Zhang
Journal:  Mol Immunol       Date:  2007-03-07       Impact factor: 4.407

8.  Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.

Authors:  Verena Hampel; Bianca Schwarz; Christine Kempf; Roberto Köstlin; Ulrike Schillinger; Helmut Küchenhoff; Nora Fenske; Thomas Brill; Johannes Hirschberger
Journal:  J Vet Intern Med       Date:  2007 Nov-Dec       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.